Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Solid Tumors × 90 days × Clear all

Status

Sponsor Class

Study Type

Interventional 30 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Osteosarcoma 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Typical Teratoid Rhabdoid Tumor 1 Thyroid Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Recurrence 1 Primary Myelofibrosis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05982873 2026-02-06

Expanded Access to Telisotuzumab Adizutecan

AbbVie

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡